GV (Google Ventures) β 2015 Investments
5 investments dated 2015 Β· listed companies and verified rows first Β· show all
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Charles Roberts(Director)inGabriel Otte(Director)in
BoardStuart Lawson(Director)
Co-investorsRA CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management CompanyAverin Capital+8 more
DNAnexus operates a cloud platform for managing, analyzing, and collaborating on multiomic and clinical data, supporting bioinformatics workflows, AI/ML analytics, and cohort analysis.
AI & Machine LearningBiotechCloud ComputingData & InfrastructureMountain View, US
Richard Daly(Executive Officer, Director)George Asimenos, PhD(Chief Product Officer)inMichael Goldberg(Director)Nathaniel Goldhaber(Director)Andreas Sundquist(Executive Officer, Director)Krishna Yeshwant(Director)
Board seatKrishna YeshwantΒ· per SEC Form D
Co-investorsClaremont Creek VenturesForesite CapitalK9 VenturesUncork CapitalWireframe Ventures
PatientPing connects patient behavioral and physical health data across providers, health plans, and government agencies to automate care coordination and reduce unnecessary utilization.
Digital HealthEnterprise SoftwareHealthtechBoston, US
Jay Desai(Executive Officer, Director)Jeff Smith(CEO, Bamboo Health)
Board seatKrishna YeshwantΒ· per SEC Form D Β· $9.7M raise Β· filed Nov 2015
Co-investorsAndreessen HorowitzF-Prime CapitalTRANSFORMATION CAPITAL
Premise provides data-driven market intelligence and geospatial insights by combining machine learning with human intelligence from a global network of contributors.
AI & Machine LearningData & InfrastructureSan Francisco, US
Joseph Reisinger(Director)David Soloff(Executive Officer, Director)
BoardChamath Palihapitiya(Director)Lawrence Summers(Director)
Board seatKarim FarisΒ· per SEC Form D Β· $50M raise Β· filed Sep 2015
Co-investorsBowery CapitalCommunitas Capital PartnersNightDragonValor Equity Partners8VCSocial Capital Partnership+1 more
Blue Bottle Coffee is a specialty coffee company that roasts and sells single-origin coffees, signature blends, matcha, and instant coffee through direct-to-consumer subscriptions and physical cafes, offering curated tasting experiences and a membership rewards program.
ConsumerDirect to ConsumerFoodTechSan Francisco, US
James Freeman(Founder of Issuer)Bryan Meehan(Founder of Issuer)Mike Volpi(Director)
BoardMichelangelo Volpi(Director)Tony Conrad(Director)in
Co-investorsAvant Global LLCBrighter CapitalCollaborative FundKindred VenturesRaptor GroupTrue Ventures+3 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.